NME1 Antikörper
Kurzübersicht für NME1 Antikörper (ABIN5704006)
Target
Alle NME1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- NME1 antibody
-
Immunogen
- non-metastatic cells 1, protein (NM23A) expressed in
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
HeLa cells were subjected to SDS PAGE followed by western blot with FNab05762(NME1 antibody) at dilution of 1:1500
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze / thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C for 12 months
-
Haltbarkeit
- 12 months
-
-
- NME1 (Non-Metastatic Cells 1, Protein (NM23A) Expressed in (NME1))
-
Andere Bezeichnung
- NME1
-
Hintergrund
-
Synonyms: Nucleoside diphosphate kinase A (NDK A, NDP kinase A)|Granzyme A-activated DNase (GAAD)|Metastasis inhibition factor nm23|NM23-H1|Tumor metastatic process-associated protein|NME1|NDPKA|NM23
Background: This gene (NME1) was identified because of its reduced mRNA transcript levels in highly metastatic cells. Nucleoside diphosphate kinase (NDK) exists as a hexamer composed of 'A' (encoded by this gene) and 'B' (encoded by NME2) isoforms. Mutations in this gene have been identified in aggressive neuroblastomas. Two transcript variants encoding different isoforms have been found for this gene. Co-transcription of this gene and the neighboring downstream gene (NME2) generates naturally-occurring transcripts (NME1-NME2), which encodes a fusion protein comprised of sequence sharing identity with each individual gene product.
-
Molekulargewicht
- 16-20 kDa
-
Gen-ID
- 4830
-
UniProt
- P15531
-
Pathways
- Apoptose, Nucleotide Phosphorylation, Carbohydrate Homeostasis, Ribonucleoside Biosynthetic Process
Target
-